Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights
How Is the Interventional Lung Solutions Market Growth Forecast from 2025 to 2029?
The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.3 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.
The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing adoption of telemedicine and remote monitoring, increasing focus on personalized medicine, increasing popularity of robotic-assisted surgery, growing adoption of minimally invasive procedures, and increasing focus on precision medicine. Major trends in the forecast period include developing lung cancer interventions, integrating artificial intelligence in bronchoscopy systems, integrating interventional pulmonology with oncology treatments, integrating digital platforms for lung disease management, and innovating lung regeneration therapies.
Claim your free report sample now:
What Are the Key Growth Factors Supporting the Interventional Lung Solutions Market Expansion?
The increasing prevalence of respiratory diseases is expected to propel the growth of the interventional lung solutions market going forward. Respiratory diseases refer to a group of medical conditions that affect the lungs and airways, making it difficult to breathe and disrupting normal respiratory function. The increasing prevalence of respiratory diseases is due to rising air pollution levels, which contribute to chronic exposure to harmful airborne particles and irritants. Interventional lung solutions help manage respiratory diseases by providing minimally invasive procedures that improve lung function and reduce symptoms in patients with chronic pulmonary conditions. For instance, in November 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the United States saw around 8,331 tuberculosis cases, marking a 5.9% increase from 2021. Therefore, the increasing prevalence of respiratory diseases drives the interventional lung solutions market.
What Segments Are Covered in the Interventional Lung Solutions Market Report?
The interventional lung solutions market covered in this report is segmented –
1) By Product Type: Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types
2) By Technology: Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy
3) By Procedure: Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures
4) By Application: Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease, Sleep Apnea Treatment
5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) BY Bronchoscopes: Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes
2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles
3) By Pleuroscopes: Flexible Pleuroscopes, Semi-Rigid Pleuroscopes
4) By Airway Stents: Metallic Stents, Silicone Stents, Hybrid Stents
5) By Other Product Types: Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices
Which Trends Are Positively Affecting the Interventional Lung Solutions Market Expansion?
Major companies operating in the interventional lung solutions market are focusing on developing innovative technologies, such as the Ion Endoluminal System, to improve the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and enhance patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to reach small or hard-to-access lung nodules. For instance, in April 2024, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit institution, launched a new Ion Robotic Bronchoscopy platform, enhancing their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology uses fiber optics and the smallest catheter on the market to reach all areas of the lung. This platform features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of hard-to-reach peripheral lung nodules. This system provides unprecedented stability and accuracy for tissue sampling, allowing physicians to reach all 18 lung segments and improving early lung cancer detection.
Who Are the Key Players Driving the Interventional Lung Solutions Market?
Major companies operating in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH
Get the full interventional lung solutions market report here:
How Does Interventional Lung Solutions Market Growth Vary Across Major Regions?
North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional lung solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment